| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Klotho Neurosciences, Inc. (KLTO) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 3 sells. KLTO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.85M | $2.54M | - | |
| CFO | 920.3K | $482.3K | - | |
| Dir | 558.9K | $292.8K | - | |
| Dir | 60.0K | $31.4K | - | |
| Dir | 60.0K | $31.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | Chardan Capital Markets LLC | 10% Owner | Sell | 342,136 | $2.12 | $725,162.38 | -7.3% | |
| Apr 7, 2022 | Redwoods Capital LLC | 10% Owner | Buy | 37,500 | $10.00 | $375,000.00 | +1.2% | |
| Apr 4, 2022 | Redwoods Capital LLC | 10% Owner | Buy | 377,500 | $10.00 | $3,775,000.00 | +14.0% |